Xconomy

OCTOBER 7, 2016

. —Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. LIVE, FROM XCONOMY, IT’S… —Two Xconomy biotech events are on the fall calendar. —The U.S. CLINICAL NEWS.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Both Sides of the Table

JULY 23, 2013

Every time I approached Network Solutions (or any technical group in Accenture) they wrote me off as “a business guy” since I studied economics and was on the Accenture “business track.” You’re a tech guy. If you ever want a quick way to my blog, btw, you can just type that. I had had enough.

Technical Advisors 385

Technical Advisors Marketing Startup Venture Capital 385

Both Sides of the Table

JANUARY 10, 2010

I wrote a blog post related to this called Is it Time to Earn or to Learn? We were high tech at the very start of the boom. If you always planned to study a second language – START! If you have kids make sure you find ways to occasionally drive them to school or turn up at their school events.

Startup 295

Startup Email Technical Review Course 295